Steven L. Cook, who serves as the Chief Financial Officer for Omada Health, Inc. (OMDA), executed a series of stock sales totaling $814,341. These transactions were processed on July 1 and July 7, 2026. The sales were conducted under a pre-arranged 10b5-1 trading plan that was established on March 14, 2026. The executive activity comes as Omada Health shares have climbed nearly 49% over the last six months. The stock is currently trading at $22.98, supporting a market capitalization of $1.37 billion. According to InvestingPro analysis, the stock is positioned above its Fair Value, which places it on the Most Overvalued list.
On July 1, Mr. Cook sold 23,263 shares of Omada Health common stock. The price per share for these transactions ranged from $22.11 to $23.09. On July 7, he sold an additional 12,337 shares. The price range for the July 7 sales was between $23.00 and $23.30. The total proceeds from these sales amounted to $814,341.
Before executing the sales, Mr. Cook acquired a total of 35,600 shares of common stock through the exercise of stock options. These acquisitions totaled $294,070 and were made at prices ranging from $7.68 to $8.28 per share. On July 1, he acquired 23,263 shares at $8.28. On July 7, he acquired 10,601 shares at $8.28, 1,042 shares at $8.01, and 694 shares at $7.68. Some of the underlying options were fully vested and exercisable, while others are subject to a monthly vesting schedule over several years. Following these reported transactions, Mr. Cook directly holds 187,209 shares of Omada Health common stock.
Omada Health Inc. recently reported its financial results for the first quarter of 2026. The company surpassed expectations with an earnings per share (EPS) of -$0.05, compared to the anticipated -$0.08. The company's revenue reached $78 million, representing a 42% increase compared to the same period last year. In addition to the earnings report, Omada Health held its 2026 Annual Meeting of Stockholders. During the meeting, Sean Duffy and Trevor Fetter were elected as Class I Directors to serve until the 2029 annual meeting. The election saw Duffy receiving 18,540,089 votes in favor, while Fetter received 18,538,042 votes in favor.
Meanwhile, Citizens raised its price target for Omada Health to $21 from $18, maintaining a Market Outperform rating. This reflects a positive growth outlook. Analyst Constantine Davides from Citizens highlighted that Omada Health traded at 2.5 times the firm's 2026 revenue estimate. These developments indicate a period of significant activity and interest in Omada Health.